Antimicrobials and resistance part II: Antifungals, antivirals, and antiparasitics.

Muhaj, Fiorinda F; George, Saira J; Nguyen, Celine D; Tyring, Stephen K

Muhaj, Fiorinda F; George, Saira J; Nguyen, Celine D; Tyring, Stephen K.

Afiliación

Muhaj FF; Department of Dermatology, University of Texas McGovern Medical School at Houston, Houston, Texas; Department of Dermatology, MD Anderson Cancer Center, Houston, Texas.
George SJ; Department of Dermatology, University of Texas McGovern Medical School at Houston, Houston, Texas; Department of Dermatology, MD Anderson Cancer Center, Houston, Texas.
Nguyen CD; Department of Psychology, Rice University, Houston, Texas; Center for Clinical Studies, Houston, Texas.
Tyring SK; Department of Dermatology, University of Texas McGovern Medical School at Houston, Houston, Texas; Center for Clinical Studies, Houston, Texas. Electronic address: styring@ccstexas.com.

J Am Acad Dermatol ; 86(6): 1207-1226, 2022 06.

Article en En | MEDLINE | ID: mdl-35122895

Asunto(s)

Antifúngicos; Candida; Antifúngicos/farmacología; Antifúngicos/uso terapéutico; Antiparasitarios/uso terapéutico; Antivirales/farmacología; Antivirales/uso terapéutico; Farmacorresistencia Fúngica; Humanos; Huésped Inmunocomprometido; Pruebas de Sensibilidad Microbiana

Palabras clave

Candida albicans; Candida auris; Candida glabrata; Trichophyton; acyclovir; amphotericin; antifungal resistance; antifungals; antimonials; antiparasitic; antitrematodal; antiviral; azoles; cidofovir; echinocandins; foscarnet; ganciclovir; griseofulvin; herpes simplex virus; immunocompromised patient; leishmaniasis; multidrug resistant; terbinafine; trypanosomiasis; varicella-zoster Virus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Candida / Antifúngicos Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google